FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158597917> ?p ?o ?g. }

• W2158597917 endingPage "789" @default.
• W2158597917 startingPage "785" @default.
• W2158597917 abstract "To examine the use of oral ciprofloxacin and parenteral antimicrobials in the treatment of acute infection (respiratory tract, urinary tract, blood) in hospitalized patients, with particular reference to severity of infection, outcome, and associated economic implications of each treatment.A prospective, multicenter comparative audit was conducted in the UK over an 18-month period. The audit was undertaken by clinical pharmacists who reviewed the antimicrobial treatment of patients with infective episodes, who were receiving or could have received oral therapy.Clinical pharmacists who collated the data all are employed in teaching hospitals.Patients were identified for analysis by their type of infection, severity of illness, antimicrobial prescribed, route of administration, and response to therapy. Additionally, data on costs of the antimicrobials prescribed and the supplementary costs of drug administration were calculated.Four hundred eighty-five patients were enrolled for analysis; 208 of the patients had respiratory tract infection, 112 had urinary tract infection, 138 had septicemia, and 27 had mixed infections. Sepsis scores were applied to 152 patients receiving oral ciprofloxacin and 333 patients receiving parenteral antimicrobials and yielded mean scores of 5.9 (SD 3.1, range 1-13) and 8.7 (SD 4.2, range 1-22), respectively. Of 485 patients, 188 were paired according to sepsis score results and route of administration. Resolution occurred in 133 patients (79 receiving oral and 54 receiving parenteral therapy), further therapy was required in 49 (11 oral and 38 parenteral), and treatment was withdrawn in 6 (4 oral and 2 parenteral). Microbiologic assessment yielded positive results in 227 patients (47 percent). Drug acquisition costs (based on 1 UK pound = 1.80 US $) per course of treatment were $47.23 (SD $38.32, range 5.40-218.70) for the oral group and $173.70 (SD 209.77, range 2.11-1021.40) for the parenteral group. Overall costs for treatment courses were $74.00 (SD $52.81, range 8.10-309.17) and $305.59 (SD $304.70, range 14.69-1345.00) for the two groups, respectively (p < 0.001).This study suggest that, in patients with moderate infective episodes, oral ciprofloxacin may reduce overall treatment costs compared with the use of parenteral antimicrobial agents." @default.
• W2158597917 created "2016-06-24" @default.
• W2158597917 creator A5002083189 @default.
• W2158597917 creator A5008305633 @default.
• W2158597917 creator A5012939775 @default.
• W2158597917 creator A5019143066 @default.
• W2158597917 creator A5021086336 @default.
• W2158597917 creator A5050209415 @default.
• W2158597917 creator A5058575713 @default.
• W2158597917 creator A5059708154 @default.
• W2158597917 creator A5066245688 @default.
• W2158597917 creator A5079254764 @default.
• W2158597917 creator A5082827538 @default.
• W2158597917 creator A5086478412 @default.
• W2158597917 date "1993-06-01" @default.
• W2158597917 modified "2023-09-27" @default.
• W2158597917 title "Comparative Clinical, Microbiologic, and Economic Audit of the Use of Oral Ciprofloxacin and Parenteral Antimicrobials" @default.
• W2158597917 cites W1536565168 @default.
• W2158597917 cites W1964576189 @default.
• W2158597917 cites W1966138471 @default.
• W2158597917 cites W1974394123 @default.
• W2158597917 cites W1985099746 @default.
• W2158597917 cites W1991752622 @default.
• W2158597917 cites W1992288156 @default.
• W2158597917 cites W2004184589 @default.
• W2158597917 cites W2007746656 @default.
• W2158597917 cites W2022942176 @default.
• W2158597917 cites W2033110601 @default.
• W2158597917 cites W2039983847 @default.
• W2158597917 cites W2049132251 @default.
• W2158597917 cites W2059549595 @default.
• W2158597917 cites W2073470022 @default.
• W2158597917 cites W2116060141 @default.
• W2158597917 cites W2146535530 @default.
• W2158597917 cites W2149514362 @default.
• W2158597917 cites W2498943812 @default.
• W2158597917 cites W4243364202 @default.
• W2158597917 cites W4293242440 @default.
• W2158597917 doi "https://doi.org/10.1177/106002809302700621" @default.
• W2158597917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8329804" @default.
• W2158597917 hasPublicationYear "1993" @default.
• W2158597917 type Work @default.
• W2158597917 sameAs 2158597917 @default.
• W2158597917 citedByCount "14" @default.
• W2158597917 crossrefType "journal-article" @default.
• W2158597917 hasAuthorship W2158597917A5002083189 @default.
• W2158597917 hasAuthorship W2158597917A5008305633 @default.
• W2158597917 hasAuthorship W2158597917A5012939775 @default.
• W2158597917 hasAuthorship W2158597917A5019143066 @default.
• W2158597917 hasAuthorship W2158597917A5021086336 @default.
• W2158597917 hasAuthorship W2158597917A5050209415 @default.
• W2158597917 hasAuthorship W2158597917A5058575713 @default.
• W2158597917 hasAuthorship W2158597917A5059708154 @default.
• W2158597917 hasAuthorship W2158597917A5066245688 @default.
• W2158597917 hasAuthorship W2158597917A5079254764 @default.
• W2158597917 hasAuthorship W2158597917A5082827538 @default.
• W2158597917 hasAuthorship W2158597917A5086478412 @default.
• W2158597917 hasConcept C126322002 @default.
• W2158597917 hasConcept C177713679 @default.
• W2158597917 hasConcept C178790620 @default.
• W2158597917 hasConcept C185592680 @default.
• W2158597917 hasConcept C2776012195 @default.
• W2158597917 hasConcept C2778384902 @default.
• W2158597917 hasConcept C2778512257 @default.
• W2158597917 hasConcept C4937899 @default.
• W2158597917 hasConcept C501593827 @default.
• W2158597917 hasConcept C534529494 @default.
• W2158597917 hasConcept C71924100 @default.
• W2158597917 hasConcept C77411442 @default.
• W2158597917 hasConcept C86803240 @default.
• W2158597917 hasConcept C89423630 @default.
• W2158597917 hasConceptScore W2158597917C126322002 @default.
• W2158597917 hasConceptScore W2158597917C177713679 @default.
• W2158597917 hasConceptScore W2158597917C178790620 @default.
• W2158597917 hasConceptScore W2158597917C185592680 @default.
• W2158597917 hasConceptScore W2158597917C2776012195 @default.
• W2158597917 hasConceptScore W2158597917C2778384902 @default.
• W2158597917 hasConceptScore W2158597917C2778512257 @default.
• W2158597917 hasConceptScore W2158597917C4937899 @default.
• W2158597917 hasConceptScore W2158597917C501593827 @default.
• W2158597917 hasConceptScore W2158597917C534529494 @default.
• W2158597917 hasConceptScore W2158597917C71924100 @default.
• W2158597917 hasConceptScore W2158597917C77411442 @default.
• W2158597917 hasConceptScore W2158597917C86803240 @default.
• W2158597917 hasConceptScore W2158597917C89423630 @default.
• W2158597917 hasIssue "6" @default.
• W2158597917 hasLocation W21585979171 @default.
• W2158597917 hasLocation W21585979172 @default.
• W2158597917 hasOpenAccess W2158597917 @default.
• W2158597917 hasPrimaryLocation W21585979171 @default.
• W2158597917 hasRelatedWork W1986498703 @default.
• W2158597917 hasRelatedWork W2323333312 @default.
• W2158597917 hasRelatedWork W2408010109 @default.
• W2158597917 hasRelatedWork W2419921872 @default.
• W2158597917 hasRelatedWork W2443985375 @default.
• W2158597917 hasRelatedWork W2522869319 @default.
• W2158597917 hasRelatedWork W2537284860 @default.
• W2158597917 hasRelatedWork W4235671009 @default.

• next